Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Genet. 2006 May;22(5):281-9. Epub 2006 Mar 29.

A decade of modeling Alzheimer's disease in transgenic mice.

Author information

1
Department of Neuroscience, Mayo Clinic College of Medicine, 4500 San Pablo Road, Jacksonville, FL 32224, USA. mcgowan.eileen@mayo.edu

Abstract

It has been over a decade since the first Alzheimer's disease (AD) transgenic mouse models were reported. These models have enabled dramatic advances in our understanding of the pathogenic mechanism in AD and of potential therapeutic approaches to tackling the inexorable clinical progression of the disease. In this article, we discuss the current status of AD mouse models and focus on recent work that has examined the development of the neuropathological lesions observed in AD (plaques and tangles). The relationship between these lesions, neurodegeneration and development of the clinical syndrome will be explored.

PMID:
16567017
DOI:
10.1016/j.tig.2006.03.007
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center